Is withZeta Driving a Re-Valuation of Lantern Pharma?

$LTRN What happens in June? Lantern Pharma has announced a dedicated June webcast focused on withZeta, its AI platform business. The most important question isn’t about the pipeline. It’s whether management starts presenting Lantern as more than a biotech company. Will we hear about: • Paying customers? • Subscription revenue? • Strategic partnerships? • A spin-off or independent entity for withZeta? • A roadmap to commercialize the platform? If withZeta is positioned as a standalone business, J